Resumen
The adrenal gland is often the site of metastasis coming from different primary tumors, including lung, kidney, breast, gastrointestinal cancer and melanoma. Metastasis-directed therapy is not yet well standardized and a multidisciplinary assessment is relevant for planning adequate management. Minimally invasive adrenalectomy is the most common treatment option, and many reports are available in the literature, demonstrating its feasibility. Previous studies showed increased survival in selected patients treated who had an adrenalectomy for metastasis, but all these findings remained inconsistent due to heterogeneous baseline clinical conditions, primary histology and tumor staging. Therefore, further investigations are needed to define the ideal candidate for adrenal metastasectomy in case of oligometastatic diseases. In the present report, we present the oncological outcome of a minimally invasive adrenalectomy for isolated adrenal metastasis, and the impact of primary histology on cancer-specific survival probability.